# Alpha Down Electroencephalography (EEG) Neurofeedback for Alcohol Use Disorder: Feasibility Trial

> **NCT07746154** · NA · NOT_YET_RECRUITING · sponsor: **Brigham and Women's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Alcohol Use Disorder (AUD)

## Interventions

- **DEVICE:** EEG Neurofeedback

## Key facts

- **NCT ID:** NCT07746154
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12-01
- **Primary completion:** 2027-12-01
- **Final completion:** 2028-02-01
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2026-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07746154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07746154, "Alpha Down Electroencephalography (EEG) Neurofeedback for Alcohol Use Disorder: Feasibility Trial". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07746154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*